These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

193 related items for PubMed ID: 25759029

  • 1. Cytokine response in mouse bone marrow derived macrophages after infection with pathogenic and non-pathogenic Rift Valley fever virus.
    Roberts KK, Hill TE, Davis MN, Holbrook MR, Freiberg AN.
    J Gen Virol; 2015 Jul; 96(Pt 7):1651-1663. PubMed ID: 25759029
    [Abstract] [Full Text] [Related]

  • 2. Using reverse genetics to manipulate the NSs gene of the Rift Valley fever virus MP-12 strain to improve vaccine safety and efficacy.
    Kalveram B, Lihoradova O, Indran SV, Ikegami T.
    J Vis Exp; 2011 Nov 01; (57):e3400. PubMed ID: 22083261
    [Abstract] [Full Text] [Related]

  • 3. Characterization of Rift Valley fever virus MP-12 strain encoding NSs of Punta Toro virus or sandfly fever Sicilian virus.
    Lihoradova OA, Indran SV, Kalveram B, Lokugamage N, Head JA, Gong B, Tigabu B, Juelich TL, Freiberg AN, Ikegami T.
    PLoS Negl Trop Dis; 2013 Nov 01; 7(4):e2181. PubMed ID: 23638202
    [Abstract] [Full Text] [Related]

  • 4. Attenuation of pathogenic Rift Valley fever virus strain through the chimeric S-segment encoding sandfly fever phlebovirus NSs or a dominant-negative PKR.
    Nishiyama S, Slack OA, Lokugamage N, Hill TE, Juelich TL, Zhang L, Smith JK, Perez D, Gong B, Freiberg AN, Ikegami T.
    Virulence; 2016 Nov 16; 7(8):871-881. PubMed ID: 27248570
    [Abstract] [Full Text] [Related]

  • 5. Rift Valley fever virus MP-12 vaccine encoding Toscana virus NSs retains neuroinvasiveness in mice.
    Indran SV, Lihoradova OA, Phoenix I, Lokugamage N, Kalveram B, Head JA, Tigabu B, Smith JK, Zhang L, Juelich TL, Gong B, Freiberg AN, Ikegami T.
    J Gen Virol; 2013 Jul 16; 94(Pt 7):1441-1450. PubMed ID: 23515022
    [Abstract] [Full Text] [Related]

  • 6. Mechanistic Insight into the Host Transcription Inhibition Function of Rift Valley Fever Virus NSs and Its Importance in Virulence.
    Terasaki K, Ramirez SI, Makino S.
    PLoS Negl Trop Dis; 2016 Oct 16; 10(10):e0005047. PubMed ID: 27711108
    [Abstract] [Full Text] [Related]

  • 7. MP-12 virus containing the clone 13 deletion in the NSs gene prevents lethal disease when administered after Rift Valley fever virus infection in hamsters.
    Gowen BB, Westover JB, Sefing EJ, Bailey KW, Nishiyama S, Wandersee L, Scharton D, Jung KH, Ikegami T.
    Front Microbiol; 2015 Oct 16; 6():651. PubMed ID: 26175722
    [Abstract] [Full Text] [Related]

  • 8. The dominant-negative inhibition of double-stranded RNA-dependent protein kinase PKR increases the efficacy of Rift Valley fever virus MP-12 vaccine.
    Lihoradova O, Kalveram B, Indran SV, Lokugamage N, Juelich TL, Hill TE, Tseng CT, Gong B, Fukushi S, Morikawa S, Freiberg AN, Ikegami T.
    J Virol; 2012 Jul 16; 86(14):7650-61. PubMed ID: 22573861
    [Abstract] [Full Text] [Related]

  • 9. Rift Valley fever virus 78kDa envelope protein attenuates virus replication in macrophage-derived cell lines and viral virulence in mice.
    Terasaki K, Kalveram B, Johnson KN, Juelich T, Smith JK, Zhang L, Freiberg AN, Makino S.
    PLoS Negl Trop Dis; 2021 Sep 16; 15(9):e0009785. PubMed ID: 34516560
    [Abstract] [Full Text] [Related]

  • 10. Rift Valley fever virus NSs protein promotes post-transcriptional downregulation of protein kinase PKR and inhibits eIF2alpha phosphorylation.
    Ikegami T, Narayanan K, Won S, Kamitani W, Peters CJ, Makino S.
    PLoS Pathog; 2009 Feb 16; 5(2):e1000287. PubMed ID: 19197350
    [Abstract] [Full Text] [Related]

  • 11. The NSs Protein Encoded by the Virulent Strain of Rift Valley Fever Virus Targets the Expression of Abl2 and the Actin Cytoskeleton of the Host, Affecting Cell Mobility, Cell Shape, and Cell-Cell Adhesion.
    Bamia A, Marcato V, Boissière M, Mansuroglu Z, Tamietti C, Romani M, Simon D, Tian G, Niedergang F, Panthier JJ, Flamand M, Souès S, Bonnefoy E.
    J Virol; 2020 Dec 09; 95(1):. PubMed ID: 33087469
    [Abstract] [Full Text] [Related]

  • 12. Rift Valley Fever Virus MP-12 Vaccine Is Fully Attenuated by a Combination of Partial Attenuations in the S, M, and L Segments.
    Ikegami T, Hill TE, Smith JK, Zhang L, Juelich TL, Gong B, Slack OA, Ly HJ, Lokugamage N, Freiberg AN.
    J Virol; 2015 Jul 09; 89(14):7262-76. PubMed ID: 25948740
    [Abstract] [Full Text] [Related]

  • 13. Chemotactic and inflammatory responses in the liver and brain are associated with pathogenesis of Rift Valley fever virus infection in the mouse.
    Gray KK, Worthy MN, Juelich TL, Agar SL, Poussard A, Ragland D, Freiberg AN, Holbrook MR.
    PLoS Negl Trop Dis; 2012 Jul 09; 6(2):e1529. PubMed ID: 22389738
    [Abstract] [Full Text] [Related]

  • 14. NSs Virulence Factor of Rift Valley Fever Virus Engages the F-Box Proteins FBXW11 and β-TRCP1 To Degrade the Antiviral Protein Kinase PKR.
    Kainulainen M, Lau S, Samuel CE, Hornung V, Weber F.
    J Virol; 2016 Jul 01; 90(13):6140-7. PubMed ID: 27122577
    [Abstract] [Full Text] [Related]

  • 15. Rift Valley fever virus clearance and protection from neurologic disease are dependent on CD4+ T cell and virus-specific antibody responses.
    Dodd KA, McElroy AK, Jones ME, Nichol ST, Spiropoulou CF.
    J Virol; 2013 Jun 01; 87(11):6161-71. PubMed ID: 23536675
    [Abstract] [Full Text] [Related]

  • 16. Post-exposure vaccination with MP-12 lacking NSs protects mice against lethal Rift Valley fever virus challenge.
    Gowen BB, Bailey KW, Scharton D, Vest Z, Westover JB, Skirpstunas R, Ikegami T.
    Antiviral Res; 2013 May 01; 98(2):135-43. PubMed ID: 23523764
    [Abstract] [Full Text] [Related]

  • 17. Rift Valley fever virus inhibits a pro-inflammatory response in experimentally infected human monocyte derived macrophages and a pro-inflammatory cytokine response may be associated with patient survival during natural infection.
    McElroy AK, Nichol ST.
    Virology; 2012 Jan 05; 422(1):6-12. PubMed ID: 22018491
    [Abstract] [Full Text] [Related]

  • 18. Rescue of infectious rift valley fever virus entirely from cDNA, analysis of virus lacking the NSs gene, and expression of a foreign gene.
    Ikegami T, Won S, Peters CJ, Makino S.
    J Virol; 2006 Mar 05; 80(6):2933-40. PubMed ID: 16501102
    [Abstract] [Full Text] [Related]

  • 19. Favipiravir (T-705) protects against peracute Rift Valley fever virus infection and reduces delayed-onset neurologic disease observed with ribavirin treatment.
    Scharton D, Bailey KW, Vest Z, Westover JB, Kumaki Y, Van Wettere A, Furuta Y, Gowen BB.
    Antiviral Res; 2014 Apr 05; 104():84-92. PubMed ID: 24486952
    [Abstract] [Full Text] [Related]

  • 20. Lithium inhibits NF-κB nuclear translocation and modulate inflammation profiles in Rift valley fever virus-infected Raw 264.7 macrophages.
    Makola RT, Kgaladi J, More GK, Jansen van Vuren P, Paweska JT, Matsebatlela TM.
    Virol J; 2021 Jun 04; 18(1):116. PubMed ID: 34088327
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.